| scholarly article | Q13442814 |
| P356 | DOI | 10.1177/0883073807309783 |
| P698 | PubMed publication ID | 18182647 |
| P2093 | author name string | Beth A Malow | |
| Susan G McGrew | |||
| Ivy M Andersen | |||
| JoAnna Kaczmarska | |||
| P433 | issue | 5 | |
| P921 | main subject | autism | Q38404 |
| autistic child | Q110955678 | ||
| melatonin | Q180912 | ||
| autism spectrum disorder | Q1436063 | ||
| insomnia | Q1869874 | ||
| P1104 | number of pages | 4 | |
| P304 | page(s) | 482-485 | |
| P577 | publication date | 2008-01-08 | |
| P1433 | published in | Journal of Child Neurology | Q6294935 |
| P1476 | title | Melatonin for insomnia in children with autism spectrum disorders | |
| P478 | volume | 23 |
| Q28661706 | Advances in the research of melatonin in autism spectrum disorders: literature review and new perspectives |
| Q26766668 | Autism and sleep disorders |
| Q28080719 | Autism as a disorder of biological and behavioral rhythms: toward new therapeutic perspectives |
| Q48189563 | Autism before diagnosis: crying, feeding and sleeping problems in the first two years of life |
| Q37703975 | Autism spectrum disorders in tuberous sclerosis: pathogenetic pathways and implications for treatment |
| Q48232008 | CYP1A2 polymorphisms in slow melatonin metabolisers: a possible relationship with autism spectrum disorder? |
| Q33971265 | Circadian-related sleep disorders and sleep medication use in the New Zealand blind population: an observational prevalence survey. |
| Q37768083 | Clinical management of behavioral insomnia of childhood: treatment of bedtime problems and night wakings in young children |
| Q21296744 | Clinical uses of melatonin in pediatrics |
| Q34961333 | Complementary alternative medicine for children with autism: a physician survey |
| Q38107509 | Complementary and alternative medicine for autism spectrum disorders: rationale, safety and efficacy. |
| Q37774100 | Complementary and alternative medicine in autism: an evidence-based approach to negotiating safe and efficacious interventions with families |
| Q22252305 | Complementary and alternative medicine treatments for children with autism spectrum disorders |
| Q22252334 | Convulsing toward the pathophysiology of autism |
| Q33704992 | Disruption of melatonin synthesis is associated with impaired 14-3-3 and miR-451 levels in patients with autism spectrum disorders |
| Q38093464 | Does melatonin affect epileptic seizures? |
| Q37706525 | Epidemiology and management of insomnia in children with autistic spectrum disorders |
| Q38056698 | Gabapentin shows promise in treating refractory insomnia in children. |
| Q33640009 | Identification of pathway-biased and deleterious melatonin receptor mutants in autism spectrum disorders and in the general population |
| Q47660446 | Incontinence in autism spectrum disorder: a systematic review |
| Q26853147 | Is sleep essential for neural plasticity in humans, and how does it affect motor and cognitive recovery? |
| Q46097471 | La mélatonine pour traiter les troubles du sommeil chez les enfants et les adolescents |
| Q27012836 | Melatonin Treatment in Children with Developmental Disabilities |
| Q33839140 | Melatonin as a Novel Interventional Candidate for Fragile X Syndrome with Autism Spectrum Disorder in Humans |
| Q34634252 | Melatonin for sleep in children with autism: a controlled trial examining dose, tolerability, and outcomes |
| Q42210550 | Melatonin for the management of sleep disorders in children and adolescents |
| Q28390468 | Melatonin in children with autism spectrum disorders: endogenous and pharmacokinetic profiles in relation to sleep |
| Q33832237 | Melatonin in children with autistic spectrum disorders: recent and practical data |
| Q34022705 | Melatonin versus placebo in children with autism spectrum conditions and severe sleep problems not amenable to behaviour management strategies: a randomised controlled crossover trial. |
| Q38174535 | Melatonin: an option for managing sleep disorders in children with autism spectrum disorder |
| Q37235719 | New approaches in the management of insomnia: weighing the advantages of prolonged-release melatonin and synthetic melatoninergic agonists |
| Q48127547 | Pain as a predictor of sleep problems in youth with autism spectrum disorders |
| Q34121926 | Parent-reported health care expenditures associated with autism spectrum disorders in Heilongjiang province, China |
| Q58117225 | Pharmacological Approach to Sleep Disturbances in Autism Spectrum Disorders with Psychiatric Comorbidities: A Literature Review |
| Q33521748 | Pharmacological management in children and adolescents with pervasive developmental disorder |
| Q47619565 | Practitioner Review: Treatment of chronic insomnia in children and adolescents with neurodevelopmental disabilities |
| Q38739577 | Psychopharmacological interventions in autism spectrum disorder |
| Q50311469 | Psychopharmacology of autism spectrum disorders |
| Q37101390 | Relation of Melatonin to Sleep Architecture in Children with Autism |
| Q64054400 | Shank3 modulates sleep and expression of circadian transcription factors |
| Q38683706 | Sleep Disturbances in Neurodevelopmental Disorders. |
| Q37449624 | Sleep behaviors and sleep quality in children with autism spectrum disorders. |
| Q38684197 | Sleep in Children with Autism Spectrum Disorder. |
| Q48424138 | Sleep in children with autism spectrum disorders |
| Q37155965 | Sleep in children with autism spectrum disorders |
| Q37889017 | Sleep in children with cerebral palsy: a review |
| Q38286448 | Sleep, epilepsy, and autism |
| Q36795315 | Sleep-related melatonin use in healthy children |
| Q65000720 | Systematic Review of Sleep Disturbances and Circadian Sleep Desynchronization in Autism Spectrum Disorder: Toward an Integrative Model of a Self-Reinforcing Loop. |
| Q47557719 | The Relationship between Autism Spectrum Disorder and Melatonin during Fetal Development. |
| Q37976331 | The medical care of children with autism |
| Q30436298 | The melatonin receptor agonist ramelteon effectively treats insomnia and behavioral symptoms in autistic disorder |
| Q24612945 | The neurology of autism spectrum disorders |
| Q34658005 | The serotonin-N-acetylserotonin-melatonin pathway as a biomarker for autism spectrum disorders |
| Q37814149 | The use of exogenous melatonin in delayed sleep phase disorder: a meta-analysis |
| Q22251419 | Update on autism: A review of 1300 reports published in 2008 |
| Q54859023 | Utilisation de la mélatonine pour le sommeil chez les enfants en bonne santé. |
| Q47812079 | What Have Proteomic Studies Taught Us About Novel Drug Targets in Autism? |
| Q38193069 | What's in the pipeline? Drugs in development for autism spectrum disorder |
Search more.